Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

BLLN

Billiontoone Inc

Nov 14 • 04:00PM ET

90.00

+0.45 0.50 %

Healthcare • Diagnostics & Research • USA • NASD

Index	-	P/E	-	EPS (ttm)	-0.68	Insider Own	51.41%	Shs Outstand	40.17M	Perf Week	-10.03%
Market Cap	4.02B	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	21.73M	Perf Month	-
Enterprise Value	4.36B	PEG	-	EPS next Q	-	Inst Own	-	Short Float	-	Perf Quarter	-
Income	-30.61M	P/S	19.25	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-
Sales	209.03M	P/B	-	EPS next Y	-	ROA	-	Short Interest	-	Perf YTD	-17.39%
Book/sh	-5.60	P/C	21.30	EPS next 5Y	-	ROE	-	52W High	123.84 -27.33%	Perf Year	-
Cash/sh	4.23	P/FCF	-	EPS past 3/5Y	- -	ROIC	-11.34%	52W Low	89.05 1.07%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	60.93%	Volatility	10.73% -	Perf 5Y	-
Dividend TTM	-	EV/Sales	20.87	EPS Y/Y TTM	-	Oper. Margin	-13.52%	ATR (14)	13.51	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.58	Sales Y/Y TTM	-	Profit Margin	-14.65%	RSI (14)	-	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	5.92	EPS Q/Q	92.59%	SMA20	-9.52%	Beta	-	Target Price	-
Payout	-	Debt/Eq	0.63	Sales Q/Q	84.11%	SMA50	-9.52%	Rel Volume	0.27	Prev Close	89.55
Employees	-	LT Debt/Eq	0.60	Earnings	-	SMA200	-9.52%	Avg Volume	447.01K	Price	90.00
IPO	Nov 06, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	122,613	Change	0.50%

Nov-07-25 04:05PM	BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire) -8.18%
Nov-06-25 05:02PM	Gunderson Dettmer Represents Long-Time Client BillionToOne in its Upsized $273.1 Million Initial Public Offering (PR Newswire)
03:39PM	What Shutdown? The IPO Window Is Still Open for Some Companies (Barrons.com)
Nov-05-25 09:53PM	BillionToOne Announces Pricing of Upsized Initial Public Offering (GlobeNewswire)

BillionToOne, Inc. develops DNA molecular counting technology. It can detect disorders such as sickle cell disease and cystic fibrosis. The company was founded by Oguzhan Atay, Sukrit Silas, and David Tsao and is headquartered in Palo Alto, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BLLN

Billiontoone Inc

Upgrade your FINVIZ experience